Genflow Biosciences (LSE:GENF), an LSE-listed longevity research company, has announced that independent non-executive chairman Gad Berdugo will attend the BIO International Convention in San Diego, running 22 to 25 June.
Berdugo is set to join a panel titled "RNA Therapeutics: Where Will We See the Greatest Technical Advances and Continued Clinical Validation in the Next 3-5 Years?"
The BIO International Convention draws biotechnology companies, academic institutions, investors and policymakers from around the world to discuss scientific innovation and emerging healthcare technologies.
